Baicalein-corrected gut microbiota may underlie the amelioration of memory and cognitive deficits in APP/PS1 mice

Background: Baicalein is an active ingredient extracted from the root of S. baicalensis Georgi, which exhibits cardiovascular protection, anti-inflammatory, and anti-microbial properties. Our previous study showed that chronic treatment of Baicalein ameliorated cognitive dysfunction in a mouse model of Alzheimer's disease (AD). However, it remains unknown whether Baicalein ameliorates cognitive deficits in AD mouse models by altering gut microbiota and its metabolites. Methods: Behavioral tests, metagenomic and untargeted metabolomics analyses were used to evaluate the effects of Baicalein on the APP/PS1 mice. Results: Our research showed that treatment of Baicalein for 2 weeks ameliorated cognition and memory in a dose-dependent manner, as indicated by the significant increases in the Discrimination index and Number of crossings and decrease in latency to the previous platform location in 8-month of age APP/PS1 mice in novel object recognition and water maze tests. The metagenomic analysis showed the abundance of the dominant phyla in all groups, including Bacteroidetes (14.59%–67.02%) and Firmicutes (20.19%–61.39%). LEfSe analysis of metagenomics identified three species such as s__Roseburia_sp_1XD42_69, s__Muribaculaceae_bacterium_Isolate_104_HZI, s__Muribaculaceae_bacterium_Isolate_110_HZI as Baicalein-treated potential biomarkers. Metabolite analysis revealed the increment of metabolites, including glutamate, thymine and hexanoyl-CoA. Conclusion: The effects of Baicalein on memory and cognition may relate to the metabolism of nucleotides, lipids and glucose.

[1]  Tianyuan Zhang,et al.  Baicalein Ameliorates Aβ-Induced Memory Deficits and Neuronal Atrophy via Inhibition of PDE2 and PDE4 , 2021, Frontiers in Pharmacology.

[2]  L. Hritcu,et al.  Baicalein 5,6-Dimethyl Ether Prevents Memory Deficits in the Scopolamine Zebrafish Model by Regulating Cholinergic and Antioxidant Systems , 2021, Plants.

[3]  D. Bredesen,et al.  Neuroprotective Herbs for the Management of Alzheimer’s Disease , 2021, Biomolecules.

[4]  V. Uversky,et al.  Baicalein inhibits heparin-induced Tau aggregation by initializing non-toxic Tau oligomer formation , 2021, Cell communication and signaling : CCS.

[5]  G. Frisoni,et al.  Short-Chain Fatty Acids and Lipopolysaccharide as Mediators Between Gut Dysbiosis and Amyloid Pathology in Alzheimer's Disease. , 2020, Journal of Alzheimer's disease : JAD.

[6]  A. Zonderman,et al.  Helicobacter pylori, periodontal pathogens, and their interactive association with incident all-cause and Alzheimer’s disease dementia in a large national survey , 2020, Molecular Psychiatry.

[7]  Huidong Tang,et al.  Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota , 2019, Alzheimer's & Dementia.

[8]  I. Mook‐Jung,et al.  Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer’s disease animal model , 2019, Gut.

[9]  A. Konnerth,et al.  A vicious cycle of β amyloid–dependent neuronal hyperactivation , 2019, Science.

[10]  M. Catani,et al.  Niacin in the Central Nervous System: An Update of Biological Aspects and Clinical Applications , 2019, International journal of molecular sciences.

[11]  Jeffrey L. Cummings,et al.  Treatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options , 2019, Journal of Alzheimer's disease : JAD.

[12]  Shuqun Zhang,et al.  Baicalein induces apoptosis and autophagy of breast cancer cells via inhibiting PI3K/AKT pathway in vivo and vitro , 2018, Drug design, development and therapy.

[13]  S. Mande,et al.  Diet, Microbiota and Gut-Lung Connection , 2018, Front. Microbiol..

[14]  A. Saykin,et al.  Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study , 2018, PLoS medicine.

[15]  R. Tanzi,et al.  Antibiotic-induced perturbations in microbial diversity during post-natal development alters amyloid pathology in an aged APPSWE/PS1ΔE9 murine model of Alzheimer’s disease , 2017, Scientific Reports.

[16]  G. Du,et al.  Therapeutic effects of baicalein on rotenone-induced Parkinson’s disease through protecting mitochondrial function and biogenesis , 2017, Scientific Reports.

[17]  R. Aiese Cigliano,et al.  The hypothesis that Helicobacter pylori predisposes to Alzheimer’s disease is biologically plausible , 2017, Scientific Reports.

[18]  Di Wang,et al.  The Neuroprotective Properties of Hericium erinaceus in Glutamate-Damaged Differentiated PC12 Cells and an Alzheimer’s Disease Mouse Model , 2016, International journal of molecular sciences.

[19]  Bo Wei,et al.  The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer’s disease , 2016, Behavioural Brain Research.

[20]  T. Sakurai,et al.  Nicotinamide mononucleotide protects against β-amyloid oligomer-induced cognitive impairment and neuronal death , 2016, Brain Research.

[21]  Desmond O'Neill,et al.  Drug treatments in Alzheimer's disease. , 2016, Clinical medicine.

[22]  J. O'Donnell,et al.  Inhibition of phosphodiesterase 2 reverses impaired cognition and neuronal remodeling caused by chronic stress , 2015, Neurobiology of Aging.

[23]  Walter H. Backes,et al.  Blood–brain barrier impairment in dementia: Current and future in vivo assessments , 2015, Neuroscience & Biobehavioral Reviews.

[24]  Chao Xie,et al.  Fast and sensitive protein alignment using DIAMOND , 2014, Nature Methods.

[25]  Yang Yang,et al.  Helicobacter pylori filtrate induces Alzheimer-like tau hyperphosphorylation by activating glycogen synthase kinase-3β. , 2014, Journal of Alzheimer's disease : JAD.

[26]  Kunihiko Sadakane,et al.  MEGAHIT: an ultra-fast single-node solution for large and complex metagenomics assembly via succinct de Bruijn graph , 2014, Bioinform..

[27]  D. Wei,et al.  Ameliorative effects of baicalein on an amyloid-β induced Alzheimer's disease rat model: a proteomics study. , 2014, Current Alzheimer research.

[28]  Björn Usadel,et al.  Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..

[29]  Eosu Kim,et al.  Metabolomic signatures in peripheral blood associated with Alzheimer's disease amyloid-β-induced neuroinflammation. , 2014, Journal of Alzheimer's disease : JAD.

[30]  T. Dinan,et al.  Mind-altering Microorganisms: the Impact of the Gut Microbiota on Brain and Behaviour , 2022 .

[31]  Edward C. Uberbacher,et al.  Gene and translation initiation site prediction in metagenomic sequences , 2012, Bioinform..

[32]  F. Panza,et al.  Glycerophospholipids and glycerophospholipid-derived lipid mediators: a complex meshwork in Alzheimer's disease pathology. , 2011, Progress in lipid research.

[33]  S. Rapoport,et al.  Disturbed choline plasmalogen and phospholipid fatty acid concentrations in Alzheimer's disease prefrontal cortex. , 2011, Journal of Alzheimer's disease : JAD.

[34]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[35]  Cole Trapnell,et al.  Ultrafast and memory-efficient alignment of short DNA sequences to the human genome , 2009, Genome Biology.

[36]  D. Bennett,et al.  Dietary niacin and the risk of incident Alzheimer’s disease and of cognitive decline , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[37]  Adam Godzik,et al.  Clustering of highly homologous sequences to reduce the size of large protein databases , 2001, Bioinform..